SPDR S&P Biotech ETF (NYSEARCA:XBI) Position Increased by United Capital Management of KS Inc.

United Capital Management of KS Inc. lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,115 shares of the exchange traded fund’s stock after purchasing an additional 2,588 shares during the period. SPDR S&P Biotech ETF makes up 2.8% of United Capital Management of KS Inc.’s investment portfolio, making the stock its 8th largest holding. United Capital Management of KS Inc.’s holdings in SPDR S&P Biotech ETF were worth $15,591,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund raised its position in SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after acquiring an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new position in SPDR S&P Biotech ETF during the third quarter worth about $141,284,000. Proficio Capital Partners LLC raised its position in SPDR S&P Biotech ETF by 16,156.1% during the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after acquiring an additional 911,686 shares during the last quarter. Raymond James Financial Inc. acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $55,529,000. Finally, Mirae Asset Securities USA Inc. raised its position in SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after acquiring an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.3 %

Shares of XBI opened at $87.13 on Friday. The stock has a market cap of $5.75 billion, a P/E ratio of 11.47 and a beta of 0.93. The company has a 50-day moving average of $90.06 and a two-hundred day moving average of $94.86. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.